B. Lebkiri

Evaluation of parameters for adequate dialysis therapy: (1). Monitoring of parameters by urea kinetic modeling.

M. Yanai, N. Man, B. Lebkiri, 1991, Nihon Jinzo Gakkai shi.

CARNITINE IMPROVES LIPID ANOMALIES IN HAEMODIALYSIS PATIENTS

B. Lacour, J. Chanard, T. Drüeke, 1980, The Lancet.

Comparison of ketoacids and low protein diet on advanced chronic renal failure progression.

P. Jungers, P. Chauveau, N. Man, 1987, Kidney international. Supplement.

Distinct HLA class II alleles determine antibody response to vaccination with hepatitis B surface antigen.

P. Jungers, G. Albouze, A. Moynot, 1998, Kidney international.

Hepatitis C virus RNA in anti-HCV positive hemodialyzed patients: significance and therapeutic implications.

F. Carnot, C. Bréchot, S. Pol, 1993, Kidney international.

HLA genetic heterogeneity of hepatitis B vaccine response in hemodialyzed patients.

P. Jungers, G. Albouze, J. Bach, 1993, Kidney international. Supplement.

Dialysis encephalopathy: recovery after interruption of aluminium intake.

B. Lebkiri, M. Poisson, R. Mashaly, 1978, British medical journal.